These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8707408)

  • 1. Vimentin expression is not associated with poor prognosis in breast cancer.
    Seshadri R; Raymond WA; Leong AS; Horsfall DJ; McCaul K
    Int J Cancer; 1996 Jul; 67(3):353-6. PubMed ID: 8707408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis.
    Seshadri R; Leong AS; McCaul K; Firgaira FA; Setlur V; Horsfall DJ
    Int J Cancer; 1996 Apr; 69(2):135-41. PubMed ID: 8608982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein.
    Domagala W; Markiewski M; Harezga B; Dukowicz A; Osborn M
    Clin Cancer Res; 1996 Jan; 2(1):147-54. PubMed ID: 9816101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vimentin expression in benign and malignant breast epithelium.
    Heatley M; Whiteside C; Maxwell P; Toner P
    J Clin Pathol; 1993 May; 46(5):441-5. PubMed ID: 7686566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
    Siitonen SM; Kallioniemi OP; Isola JJ
    Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between keratin and vimentin expression, malignant phenotype, and survival in postmenopausal breast cancer patients.
    Thomas PA; Kirschmann DA; Cerhan JR; Folberg R; Seftor EA; Sellers TA; Hendrix MJ
    Clin Cancer Res; 1999 Oct; 5(10):2698-703. PubMed ID: 10537332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vimentin--a new prognostic parameter in breast carcinoma?
    Raymond WA; Leong AS
    J Pathol; 1989 Jun; 158(2):107-14. PubMed ID: 2547048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on p53 immunolocalisation in breast cancer and its prognostic significance.
    Meenakshi A; Manoharan V
    Hum Antibodies; 1999; 9(3):171-6. PubMed ID: 10690631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast.
    Gould VE; Koukoulis GK; Jansson DS; Nagle RB; Franke WW; Moll R
    Am J Pathol; 1990 Nov; 137(5):1143-55. PubMed ID: 1700618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vimentin in breast carcinoma, its correlation with Ki67 and other histopathological parameters.
    Hemalatha A; Suresh TN; Kumar ML
    Indian J Cancer; 2013; 50(3):189-94. PubMed ID: 24061457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognosis parameters and with the proliferation marker, MIB-1.
    Beck T; Weller EE; Weikel W; Brumm C; Wilkens C; Knapstein PG
    Gynecol Oncol; 1995 Apr; 57(1):96-104. PubMed ID: 7705708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vimentin expression does not assist in predicting survival in ductal carcinoma of the breast.
    Heatley MK; Ewings P; Odling Smee W; Maxwell P; Toner PG
    Pathology; 2002 Jun; 34(3):230-2. PubMed ID: 12109782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the CD44 glycoprotein (lymphocyte-homing receptor) in untreated human breast cancer and its relationship to prognostic markers.
    de la Torre M; Heldin P; Bergh J
    Anticancer Res; 1995; 15(6B):2791-5. PubMed ID: 8669866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine proteinase inhibitor cystatin A in breast cancer.
    Kuopio T; Kankaanranta A; Jalava P; Kronqvist P; Kotkansalo T; Weber E; Collan Y
    Cancer Res; 1998 Feb; 58(3):432-6. PubMed ID: 9458085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vimentin expression, proliferating cell nuclear antigen and flow cytometric factors. Prognostic role in breast cancer.
    Russo A; Bazan V; Morello V; Tralongo V; Nagar C; Nuara R; Dardanoni G; Bazan P; Tomasino RM
    Anal Quant Cytol Histol; 1994 Oct; 16(5):365-74. PubMed ID: 7530959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of syndecan-1 expression in breast cancer.
    Leivonen M; Lundin J; Nordling S; von Boguslawski K; Haglund C
    Oncology; 2004; 67(1):11-8. PubMed ID: 15459490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study.
    Crabb SJ; Bajdik CD; Leung S; Speers CH; Kennecke H; Huntsman DG; Gelmon KA
    Breast Cancer Res; 2008; 10(1):R6. PubMed ID: 18194560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
    Veronese SM; Maisano C; Scibilia J
    Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of the prognostic significance of epidermal growth factor receptor in primary breast cancer.
    Seshadri R; McLeay WR; Horsfall DJ; McCaul K
    Int J Cancer; 1996 Feb; 69(1):23-7. PubMed ID: 8600054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M
    Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.